West Pharmaceutical Services | WST - Net Income

Stock Price
248.31
Daily Change
2.93 1.19%
Monthly
2.86%
Yearly
13.01%
Q1 Forecast
233.65

West Pharmaceutical Services reported $132.1M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Align Technology USD 135.76M 79.01M Dec/2025
Avanos Medical USD -1.3M 100K Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Cerus USD -20.92M 17.98M Dec/2024
Charles River Laboratories USD -276.56M 330.98M Dec/2025
Cooper Companies USD 84.6M 13.7M Sep/2025
Dentsply International USD -427M 382M Sep/2025
Haemonetics USD 44.74M 6.06M Dec/2025
ICU Medical USD -15.73M 12.34M Dec/2025
Insulet USD 101.6M 14M Dec/2025
Integra LifeSciences USD -5.4M 478.67M Sep/2025
IQVIA Holdings USD 514M 183M Dec/2025
J&J USD 5.12B 36M Dec/2025
Medtronic USD 1.14B 231M Dec/2025
Merit Medical Systems USD 27.76M 4.83M Sep/2025
Neogen USD -15.92M 52.26M Sep/2025
OraSure Technologies USD -4.51M 3.89M Sep/2024
Quidel USD -733M 477.6M Sep/2025
Repligen USD 13.29M 1.62M Dec/2025
Rockwell Medical USD 343K 2.07M Jun/2024
Solventum Corp USD 1.27B 1.18B Sep/2025
STAAR Surgical USD 8.88M 25.7M Sep/2025
Terumo JPY 32.65B 2.4B Dec/2025
Utah Medical Products USD 3.01M 757K Sep/2025
West Pharmaceutical Services USD 132.1M 7.9M Dec/2025